Advanced Filters
noise
Found 64,920 clinical trials
P Pietro LAMPERTICO, Pr

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

Multicenter pharmacological observational prospective, no-profit, study. This study was designed to get a "real-life" snapshot across several Italian Hepatology centers. All HDV patients are followed up according to EASL 2017 guidelines. This allows uniformity on the indication for antiviral treatment and management of that antiviral therapy. No off-label medications are …

18 years of age All Phase N/A
G Garry Frost, Prof

Passive Dietary Intake Assessment Study

Currently, there is no accurate measurement of dietary intake. All current methodologies of assessing dietary intake have inaccuracy rates of 30 -70%. Accurate assessment of dietary intake is critical in understanding individual and population nutritional status and monitoring the effectiveness of public health interventions to maintain nutritional health. Estimating dietary …

years of age All Phase N/A
A Attila Bursics, MD PhD

SURGIcal COmplication and MIcrobiome ChangeS in Colorectal Surgery

The microbiome, the collection of microorganisms that live in our gut, plays an important role in maintaining our health, proper nutrient absorption, nutrient turnover and immunity. After birth, a symbiotic relationship develops with the strains of bacteria that colonise our gut, and the presence and proportion of bacteria is individualised …

18 years of age All Phase N/A
T Tyler Holler, MPH

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

Study is enrolling newly diagnosed breast cancer patients about to start chemotherapy and age-matched control participants. The investigator is trying to better understand the prevalence of cognitive difficulties in cancer patients receiving chemotherapy compared to the general population as well as what biological mechanisms may play a role in the …

21 years of age Female Phase N/A
S Stefano De Zanet

Effect of Gelsectan® in the Treatment of Low Anterior Resection Syndrome

Low Anterior Resection Syndrome (LARS) is an intestinal disorder affecting patients undergoing rectal resection for rectal cancer. A possible therapeutic option may be Gelsectan®, a class II device used in Irritable Bowel Syndrome (IBS). The aim of this study is to evaluate the efficacy of Gelsectan® in improving the symptoms …

18 years of age All Phase N/A
A Asher Mendelson, MD PhD

Exercise Testing in ICU Survivors to Evaluate ICU-acquired Weakness

This study aims to investigate how sepsis and shock can impair microcirculation in intensive care unit (ICU) patients, which can lead to long-lasting muscle weakness/dysfunction or ICU-Acquired Weakness (ICU-AW) and exercise limitations.

18 years of age All Phase N/A
E Elise Dupitier

Wheelchair Positioning and Neuromuscular Diseases

This database will describe sitting postural control in wheelchair, as well as PW pain, and pressure ulcers associated with sitting, in patients with neuromuscular disease (NMD).

8 years of age All Phase N/A
S Study Coordinator

UW Undiagnosed Genetic Diseases Program

The primary purpose of this study is to discover new disease genes for rare Mendelian disorders and its secondary purpose include diagnosing people with rare genetic disorders that have not been previously diagnosed through conventional clinical means, learning more about the pathobiology of genetic disorders, and developing novel diagnostic technologies …

- 100 years of age All Phase N/A
M Mahmoud Badwy, specialist

Phenotyping of the Out-of-proportion Pulmonary Hypertension

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. The complexity of managing PH requires a multidisciplinary approach, with active involvement of patients with PH in partnership with clinicians.(1) All age groups are affected. …

18 - 70 years of age All Phase N/A
Z Zhou Zhang, MD,PhD

Risk Model of Cognitive Impairment in Diabetes

Development and validation of a risk model for predicting the risk of mild cognitive impairment among individuals of type 2 diabetes.

40 - 80 years of age All Phase N/A

Simplify language using AI